These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9460553)

  • 1. Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadipoylglycylglycine (N3S-adipate).
    Kasina S; Sanderson JA; Fitzner JN; Srinivasan A; Rao TN; Hobson LJ; Reno JM; Axworthy DB; Beaumier PL; Fritzberg AR
    Bioconjug Chem; 1998; 9(1):108-17. PubMed ID: 9460553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent.
    Kasina S; Rao TN; Srinivasan A; Sanderson JA; Fitzner JN; Reno JM; Beaumier PL; Fritzberg AR
    J Nucl Med; 1991 Jul; 32(7):1445-51. PubMed ID: 2066805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for MAG3 conjugation and 99mTc radiolabeling of biomolecules.
    Wang Y; Liu G; Hnatowich DJ
    Nat Protoc; 2006; 1(3):1477-80. PubMed ID: 17406438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments.
    Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME
    Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc labeling of proteins: initial evaluation of a novel diaminedithiol bifunctional chelating agent.
    Baidoo KE; Scheffel U; Lever SZ
    Cancer Res; 1990 Feb; 50(3 Suppl):799s-803s. PubMed ID: 2297727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bis(hydroxamamide)-based bifunctional chelating agent for 99mTc labeling of polypeptides.
    Xu LC; Nakayama M; Harada K; Kuniyasu A; Nakayama H; Tomiguchi S; Kojima A; Takahashi M; Ono M; Arano Y; Saji H; Yao Z; Sakahara H; Konishi J; Imagawa Y
    Bioconjug Chem; 1999; 10(1):9-17. PubMed ID: 9893958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiolations, 99mTc labelings, and animal in vivo biodistributions of divalent monoclonal antibody fragments.
    Govindan SV; Goldenberg DM; Grebenau RC; Hansen HJ; Griffiths GL
    Bioconjug Chem; 1996; 7(3):290-7. PubMed ID: 8816950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-labelled compounds prepared with sodium dithionite as reducing agent.
    Vilcek S; Kalincák M; Machán V
    Nuklearmedizin; 1981 Dec; 20(6):283-9. PubMed ID: 6460222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium-99m-labeled monoclonal antibody with preserved immunoreactivity and high in vivo stability.
    Arano Y; Yokoyama A; Furukawa T; Horiuchi K; Yahata T; Saji H; Sakahara H; Nakashima T; Koizumi M; Endo K
    J Nucl Med; 1987 Jun; 28(6):1027-33. PubMed ID: 3585492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m labeling of murine monoclonal antibody fragments.
    Rhodes BA; Zamora PO; Newell KD; Valdez EF
    J Nucl Med; 1986 May; 27(5):685-93. PubMed ID: 3086522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved synthesis of NHS-MAG3 for conjugation and radiolabeling of biomolecules with (99m)Tc at room temperature.
    Wang Y; Liu X; Hnatowich DJ
    Nat Protoc; 2007; 2(4):972-8. PubMed ID: 17446896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of carrier on 99mTc radiopharmaceuticals.
    Ballinger JR
    Q J Nucl Med; 2002 Sep; 46(3):224-32. PubMed ID: 12134138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positioning of 99mTc-chelators influences radiolabeling, stability and biodistribution of Affibody molecules.
    Ekblad T; Orlova A; Feldwisch J; Wennborg A; Karlström AE; Tolmachev V
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3912-4. PubMed ID: 19364646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide-based bifunctional chelating agent for 99mTc- and 186Re-labeling of monoclonal antibodies.
    Ram S; Buchsbaum DJ
    Cancer; 1994 Feb; 73(3 Suppl):769-73. PubMed ID: 8306258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin receptor-binding peptides suitable for tumor radiotherapy with Re-188 or Re-186. Chemistry and initial biological studies.
    Cyr JE; Pearson DA; Wilson DM; Nelson CA; Guaraldi M; Azure MT; Lister-James J; Dinkelborg LM; Dean RT
    J Med Chem; 2007 Mar; 50(6):1354-64. PubMed ID: 17315859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Click-to-chelate": in vitro and in vivo comparison of a 99mTc(CO)3-labeled N(tau)-histidine folate derivative with its isostructural, clicked 1,2,3-triazole analogue.
    Mindt TL; Müller C; Melis M; de Jong M; Schibli R
    Bioconjug Chem; 2008 Aug; 19(8):1689-95. PubMed ID: 18646835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin(8-13) analogue: radiolabeling and biological evaluation using different chelators.
    Teodoro R; Faintuch BL; Núñez EG; Queiróz RG
    Nucl Med Biol; 2011 Jan; 38(1):113-20. PubMed ID: 21220134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design.
    Banerjee SR; Maresca KP; Francesconi L; Valliant J; Babich JW; Zubieta J
    Nucl Med Biol; 2005 Jan; 32(1):1-20. PubMed ID: 15691657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct 99mTc labeling of monoclonal antibodies: radiolabeling and in vitro stability.
    Garron JY; Moinereau M; Pasqualini R; Saccavini JC
    Int J Rad Appl Instrum B; 1991; 18(7):695-703. PubMed ID: 1787078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of radiochemically pure antibodies.
    Eckelman WC
    Cancer Res; 1990 Feb; 50(3 Suppl):780s-782s. PubMed ID: 2297723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.